Show simple item record

dc.contributor.authorHolmes, Sarah J
dc.contributor.authorIronside, J W
dc.contributor.authorShalet, Stephen M
dc.date.accessioned2010-04-08T11:40:38Z
dc.date.available2010-04-08T11:40:38Z
dc.date.issued1996-03
dc.identifier.citationNeurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood. 1996, 60 (3):333-5 J. Neurol. Neurosurg. Psychiatr.en
dc.identifier.issn0022-3050
dc.identifier.pmid8609514
dc.identifier.doi10.1136/jnnp.60.3.333
dc.identifier.urihttp://hdl.handle.net/10541/95993
dc.description.abstractThe case of a young man who had previously received pituitary derived growth hormone for treatment of radiation induced growth hormone deficiency is reported. He underwent neurosurgery for presumed recurrence of a posterior fossa tumour but was subsequently shown to have Creutzfeldt-Jakob disease, confirmed on necropsy. The risk of transmission of Creutzfeldt-Jakob disease by neurosurgical instruments is discussed. Since the occurrence of this case the Department of Health have issued guidelines concerning neurosurgery and ophthalmic surgery in patients who have previously received treatment with pituitary derived growth hormone and may therefore be at risk of developing Creutzfeldt-Jakob disease. Surgical instruments used on such patients should under no circumstances be reused, and should be destroyed after use.
dc.language.isoenen
dc.subjectCerebellar Canceren
dc.subject.meshAstrocytoma
dc.subject.meshCerebellar Neoplasms
dc.subject.meshChild
dc.subject.meshCreutzfeldt-Jakob Syndrome
dc.subject.meshDrug Contamination
dc.subject.meshEquipment Contamination
dc.subject.meshFatal Outcome
dc.subject.meshGrowth Disorders
dc.subject.meshGrowth Hormone
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshPostoperative Complications
dc.titleNeurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.en
dc.typeArticleen
dc.contributor.departmentDepartment of Endocrinology, Christie Hospital NHS Trust, Manchester, UK.en
dc.identifier.journalJournal of Neurology, Neurosurgery, and Psychiatryen
html.description.abstractThe case of a young man who had previously received pituitary derived growth hormone for treatment of radiation induced growth hormone deficiency is reported. He underwent neurosurgery for presumed recurrence of a posterior fossa tumour but was subsequently shown to have Creutzfeldt-Jakob disease, confirmed on necropsy. The risk of transmission of Creutzfeldt-Jakob disease by neurosurgical instruments is discussed. Since the occurrence of this case the Department of Health have issued guidelines concerning neurosurgery and ophthalmic surgery in patients who have previously received treatment with pituitary derived growth hormone and may therefore be at risk of developing Creutzfeldt-Jakob disease. Surgical instruments used on such patients should under no circumstances be reused, and should be destroyed after use.


This item appears in the following Collection(s)

Show simple item record